These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26334317)

  • 21. Clinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinoma.
    Huang JX; Chen WC; Lin M; Zhang YL; Li FY; Song ZX; Xiao W; Chen P; Qian RY; Salminen E; Yu H
    Dis Esophagus; 2012 Feb; 25(2):121-9. PubMed ID: 21762277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Surgery and Further Treatment of Progressive Glioblastoma.
    Woernle CM; Péus D; Hofer S; Rushing EJ; Held U; Bozinov O; Krayenbühl N; Weller M; Regli L
    World Neurosurg; 2015 Aug; 84(2):301-7. PubMed ID: 25797075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme.
    Sminia P; Stoter TR; van der Valk P; Elkhuizen PH; Tadema TM; Kuipers GK; Vandertop WP; Lafleur MV; Slotman BJ
    J Cancer Res Clin Oncol; 2005 Oct; 131(10):653-61. PubMed ID: 16133570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
    Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
    BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas.
    Qiu XX; Wang CH; Lin ZX; You N; Wang XF; Chen YP; Chen L; Liu SY; Kang DZ
    J Neurosurg; 2015 Dec; 123(6):1578-85. PubMed ID: 26047413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Analysis of Vascular Endothelial Growth Factor Expression with Cyclooxygenase-2 and Mast Cell Density in Oral Squamous Cell Carcinoma.
    Akbarzadeh Baghban A; Taghavi N; Shahla M
    Pathobiology; 2017; 84(2):80-86. PubMed ID: 27577989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis.
    Owens JM; Shroyer KR; Kingdom TT
    Arch Otolaryngol Head Neck Surg; 2008 Aug; 134(8):825-31. PubMed ID: 18711055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma.
    Roberts PS; Nuño M; Sherman D; Asher A; Wertheimer J; Riggs RV; Patil CG
    PM R; 2014 Jun; 6(6):514-21. PubMed ID: 24384359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.
    Hung KS; Howng SL
    J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of Ki-67 Index with Volumetric Segmentation and its Value as a Prognostic Marker in Glioblastoma.
    Henker C; Kriesen T; Schneider B; Glass Ä; Scherer M; Langner S; Erbersdobler A; Piek J
    World Neurosurg; 2019 May; 125():e1093-e1103. PubMed ID: 30790732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients.
    Owens JM; Shroyer KR; Kingdom TT
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):579-87. PubMed ID: 16785401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis.
    Pallud J; Dezamis E; Audureau E; Devaux B; Souillard-Scemama R; Sanai N; Page P; Beuvon F; Koziak M; Oppenheim C; Dhermain F; Schlienger M; Meder JF; Roux FX; Varlet P
    J Neurosurg; 2012 Sep; 117(3):476-85. PubMed ID: 22725988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
    Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
    Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.